Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 4 |
NetGPI | no | yes: 0, no: 4 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AXV8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 262 | 266 | PF00656 | 0.507 |
CLV_MEL_PAP_1 | 28 | 34 | PF00089 | 0.490 |
CLV_NRD_NRD_1 | 314 | 316 | PF00675 | 0.436 |
CLV_PCSK_KEX2_1 | 314 | 316 | PF00082 | 0.436 |
CLV_PCSK_SKI1_1 | 315 | 319 | PF00082 | 0.464 |
DEG_APCC_DBOX_1 | 244 | 252 | PF00400 | 0.517 |
DEG_COP1_1 | 82 | 90 | PF00400 | 0.503 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.534 |
DEG_SPOP_SBC_1 | 219 | 223 | PF00917 | 0.489 |
DEG_SPOP_SBC_1 | 59 | 63 | PF00917 | 0.468 |
DOC_ANK_TNKS_1 | 73 | 80 | PF00023 | 0.489 |
DOC_CYCLIN_yCln2_LP_2 | 142 | 148 | PF00134 | 0.509 |
DOC_MAPK_MEF2A_6 | 149 | 156 | PF00069 | 0.584 |
DOC_PP2B_LxvP_1 | 99 | 102 | PF13499 | 0.740 |
DOC_PP2B_PxIxI_1 | 104 | 110 | PF00149 | 0.523 |
DOC_USP7_MATH_1 | 114 | 118 | PF00917 | 0.516 |
DOC_WW_Pin1_4 | 101 | 106 | PF00397 | 0.437 |
DOC_WW_Pin1_4 | 155 | 160 | PF00397 | 0.574 |
DOC_WW_Pin1_4 | 35 | 40 | PF00397 | 0.568 |
DOC_WW_Pin1_4 | 86 | 91 | PF00397 | 0.575 |
DOC_WW_Pin1_4 | 92 | 97 | PF00397 | 0.524 |
LIG_14-3-3_CanoR_1 | 180 | 186 | PF00244 | 0.649 |
LIG_14-3-3_CanoR_1 | 291 | 297 | PF00244 | 0.427 |
LIG_BRCT_BRCA1_1 | 44 | 48 | PF00533 | 0.543 |
LIG_BRCT_BRCA1_1 | 94 | 98 | PF00533 | 0.543 |
LIG_FHA_1 | 222 | 228 | PF00498 | 0.494 |
LIG_FHA_1 | 234 | 240 | PF00498 | 0.399 |
LIG_FHA_1 | 284 | 290 | PF00498 | 0.420 |
LIG_FHA_1 | 78 | 84 | PF00498 | 0.762 |
LIG_FHA_2 | 257 | 263 | PF00498 | 0.518 |
LIG_LIR_Apic_2 | 298 | 304 | PF02991 | 0.399 |
LIG_LIR_Gen_1 | 45 | 56 | PF02991 | 0.518 |
LIG_LIR_Gen_1 | 95 | 105 | PF02991 | 0.521 |
LIG_LIR_Nem_3 | 45 | 51 | PF02991 | 0.560 |
LIG_LIR_Nem_3 | 53 | 59 | PF02991 | 0.464 |
LIG_LIR_Nem_3 | 69 | 75 | PF02991 | 0.568 |
LIG_LIR_Nem_3 | 95 | 101 | PF02991 | 0.527 |
LIG_LYPXL_S_1 | 71 | 75 | PF13949 | 0.569 |
LIG_LYPXL_yS_3 | 72 | 75 | PF13949 | 0.569 |
LIG_MYND_1 | 246 | 250 | PF01753 | 0.516 |
LIG_MYND_1 | 92 | 96 | PF01753 | 0.665 |
LIG_NRP_CendR_1 | 318 | 319 | PF00754 | 0.485 |
LIG_SH2_PTP2 | 293 | 296 | PF00017 | 0.400 |
LIG_SH2_STAP1 | 56 | 60 | PF00017 | 0.549 |
LIG_SH2_STAT5 | 129 | 132 | PF00017 | 0.461 |
LIG_SH2_STAT5 | 233 | 236 | PF00017 | 0.653 |
LIG_SH2_STAT5 | 293 | 296 | PF00017 | 0.408 |
LIG_SH2_STAT5 | 302 | 305 | PF00017 | 0.346 |
LIG_SH2_STAT5 | 316 | 319 | PF00017 | 0.392 |
LIG_SH2_STAT5 | 56 | 59 | PF00017 | 0.467 |
LIG_SH3_3 | 153 | 159 | PF00018 | 0.579 |
LIG_SH3_3 | 84 | 90 | PF00018 | 0.564 |
LIG_SH3_3 | 99 | 105 | PF00018 | 0.446 |
LIG_SUMO_SIM_par_1 | 79 | 85 | PF11976 | 0.573 |
LIG_TRAF2_1 | 174 | 177 | PF00917 | 0.551 |
LIG_UBA3_1 | 248 | 255 | PF00899 | 0.496 |
LIG_WRC_WIRS_1 | 251 | 256 | PF05994 | 0.484 |
MOD_CK1_1 | 135 | 141 | PF00069 | 0.685 |
MOD_CK1_1 | 221 | 227 | PF00069 | 0.495 |
MOD_CK1_1 | 297 | 303 | PF00069 | 0.408 |
MOD_CK1_1 | 61 | 67 | PF00069 | 0.480 |
MOD_CK1_1 | 82 | 88 | PF00069 | 0.573 |
MOD_CK2_1 | 256 | 262 | PF00069 | 0.510 |
MOD_GlcNHglycan | 138 | 141 | PF01048 | 0.498 |
MOD_GlcNHglycan | 187 | 190 | PF01048 | 0.686 |
MOD_GlcNHglycan | 193 | 196 | PF01048 | 0.649 |
MOD_GlcNHglycan | 200 | 203 | PF01048 | 0.672 |
MOD_GlcNHglycan | 207 | 210 | PF01048 | 0.597 |
MOD_GSK3_1 | 114 | 121 | PF00069 | 0.551 |
MOD_GSK3_1 | 132 | 139 | PF00069 | 0.621 |
MOD_GSK3_1 | 176 | 183 | PF00069 | 0.560 |
MOD_GSK3_1 | 292 | 299 | PF00069 | 0.429 |
MOD_GSK3_1 | 50 | 57 | PF00069 | 0.501 |
MOD_GSK3_1 | 82 | 89 | PF00069 | 0.699 |
MOD_LATS_1 | 118 | 124 | PF00433 | 0.471 |
MOD_N-GLC_1 | 190 | 195 | PF02516 | 0.600 |
MOD_NEK2_1 | 132 | 137 | PF00069 | 0.595 |
MOD_NEK2_1 | 296 | 301 | PF00069 | 0.426 |
MOD_NEK2_2 | 250 | 255 | PF00069 | 0.491 |
MOD_OFUCOSY | 52 | 58 | PF10250 | 0.458 |
MOD_PIKK_1 | 210 | 216 | PF00454 | 0.472 |
MOD_PIKK_1 | 61 | 67 | PF00454 | 0.467 |
MOD_PK_1 | 180 | 186 | PF00069 | 0.562 |
MOD_PKA_2 | 179 | 185 | PF00069 | 0.573 |
MOD_PKA_2 | 191 | 197 | PF00069 | 0.534 |
MOD_Plk_4 | 285 | 291 | PF00069 | 0.415 |
MOD_Plk_4 | 297 | 303 | PF00069 | 0.341 |
MOD_Plk_4 | 44 | 50 | PF00069 | 0.567 |
MOD_Plk_4 | 82 | 88 | PF00069 | 0.678 |
MOD_ProDKin_1 | 101 | 107 | PF00069 | 0.439 |
MOD_ProDKin_1 | 155 | 161 | PF00069 | 0.574 |
MOD_ProDKin_1 | 35 | 41 | PF00069 | 0.562 |
MOD_ProDKin_1 | 86 | 92 | PF00069 | 0.571 |
TRG_DiLeu_BaLyEn_6 | 71 | 76 | PF01217 | 0.581 |
TRG_ENDOCYTIC_2 | 129 | 132 | PF00928 | 0.668 |
TRG_ENDOCYTIC_2 | 293 | 296 | PF00928 | 0.416 |
TRG_ENDOCYTIC_2 | 56 | 59 | PF00928 | 0.547 |
TRG_ENDOCYTIC_2 | 72 | 75 | PF00928 | 0.569 |
TRG_ER_diArg_1 | 245 | 248 | PF00400 | 0.521 |
TRG_ER_diArg_1 | 313 | 315 | PF00400 | 0.429 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IGR6 | Leishmania donovani | 83% | 99% |
A4I1S3 | Leishmania infantum | 82% | 96% |
Q4Q9L3 | Leishmania major | 75% | 99% |